Indicator of Inflammation and NETosis—Low-Density Granulocytes as a Biomarker of Autoimmune Hepatitis

W Domerecka, I Homa-Mlak, R Mlak… - Journal of Clinical …, 2022 - mdpi.com
Introduction. Interest in the potential role of low-density granulocytes (LDGs) in the
development of autoimmune diseases has been renewed recently. Due to their pro …

Does Therapy with Glucagon-like Peptide 1 Receptor Agonists Have an Effect on Biochemical Markers of Metabolic-Dysfunction-Associated Steatotic Liver Disease …

M Hachuła, M Kosowski, M Basiak, B Okopień - Pharmaceuticals, 2023 - mdpi.com
Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) is associated with the
excessive collection of lipids in hepatocytes. Over 75% of diabetes patients typically have …

Performance of noninvasive fibrosis indices in chronic hepatitis B during pretreatment and post-treatment periods

YE Ozdemir, MS Ozdemir, OF Bayramlar… - Biomarkers in …, 2023 - Taylor & Francis
Background: Pretreatment and post-treatment performances of noninvasive fibrosis indices
were determined in patients with chronic hepatitis B. Method: This was a retrospective …

[HTML][HTML] Comparative evaluation of APRI and MELD scores in the prediction of complications of chronic hepatitis in patients infected with hepatitis B or C viruses in …

A Kabamba-Tshikongo, A Baleebenga… - Journal of Clinical …, 2025 - Elsevier
The indication for treatment of viral hepatitis B and C depends on the degree of deterioration
of liver function and secondarily viral load. APRI and MELD scores are WHO-validated tests …

[PDF][PDF] Performance of non-invasive fibrosis markers in biopsy-proven liver disorders

N Danis, F Gunsar, F Yilmaz, D Nart, I Turan… - …, 2024 - hepatologyforum.org
Materials and Methods: In this single-center, cross-sectional, retrospective collected data
cohort study spanning seven consecutive years, simultaneous FS measurements, FIB-4, and …

[PDF][PDF] Renal function in patients with chronic hepatitis B during antiviral therapy.

N Čustović, L Alić, I Rašić, A Saray, A Mehmedović… - Medicinski …, 2024 - ljkzedo.ba
Aim To analyse the impact of the length of antiviral therapy with tenofovir disoproxil fumarate
(TDF) on the renal function in patients with chronic hepatitis B (CHB). Methods A cross …

Gut Microbiota Dysbiosis, Immunological Response And The Performance Of Non-Invasive Models For Assessing Liver Fibrosis In Patients With Chronic Hepatitis B …

RE Eworo, UA Fabian, NA Ntamu, CC Thomas… - Global Journal of Pure …, 2023 - ajol.info
Gut microbiota dysbiosis and lipopolysaccharide-mediated immune response has been
linked with pathogenesis of complications and liver injuries in subjects with chronic hepatitis …

A Cross-Sectional Study to Evaluate the Prevalence and Distribution of MASLD using Vibration-Controlled Transient Elastography in the General Population

G Chhaya, K Jhaveri, B Parikh - Journal of Diabetology, 2025 - journals.lww.com
Background: The increasing prevalence of metabolic dysfunction-associated steatotic liver
disease (MASLD) has plagued the general population of the world, which has revised the …

[HTML][HTML] Associated Factors for Liver Fibrosis and Histological Activity Index in Treatment-Naïve HBeAg-Positive Chronic Hepatitis B Infection: Insights from a …

KG Güçlü, C Geyiktepe-Güçlü, G Tunçer… - … Diseases & Clinical …, 2024 - pmc.ncbi.nlm.nih.gov
Objective The study aimed to identify predictors of advanced fibrosis score and histological
activity index (HAI) in HBeAg-positive patients to facilitate early disease detection and …

[HTML][HTML] Correlation of serum markers with FibroScan® liver for assessment of hepatic fibrosis in patients with non-alcoholic steatohepatitis

MM Pasha, NS Tirumala… - Journal of Clinical and …, 2023 - journals.lww.com
Background: Newer non-invasive modalities such as FibroScan and laboratory testing
methods such as aspartate aminotransferase (AST) platelet ratio index (APRI) scores …